These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Lack of pathogenic germline DICER1 variants in males with testicular germ-cell tumors. Vasta LM; McMaster ML; Harney LA; Ling A; Kim J; Harris AK; Carr AG; Damrauer SM; Rader DJ; Kember RL; Kanetsky PA; Nathanson KL; Pyle LC; Greene MH; Schultz KA; Stewart DR; Cancer Genet; 2020 Oct; 248-249():49-56. PubMed ID: 33158809 [TBL] [Abstract][Full Text] [Related]
6. Expanding the phenotype of mutations in DICER1: mosaic missense mutations in the RNase IIIb domain of DICER1 cause GLOW syndrome. Klein S; Lee H; Ghahremani S; Kempert P; Ischander M; Teitell MA; Nelson SF; Martinez-Agosto JA J Med Genet; 2014 May; 51(5):294-302. PubMed ID: 24676357 [TBL] [Abstract][Full Text] [Related]
7. The oncogenic roles of DICER1 RNase IIIb domain mutations in ovarian Sertoli-Leydig cell tumors. Wang Y; Chen J; Yang W; Mo F; Senz J; Yap D; Anglesio MS; Gilks B; Morin GB; Huntsman DG Neoplasia; 2015 Aug; 17(8):650-60. PubMed ID: 26408257 [TBL] [Abstract][Full Text] [Related]
8. Ovarian tumors related to intronic mutations in DICER1: a report from the international ovarian and testicular stromal tumor registry. Schultz KA; Harris A; Messinger Y; Sencer S; Baldinger S; Dehner LP; Hill DA Fam Cancer; 2016 Jan; 15(1):105-10. PubMed ID: 26289771 [TBL] [Abstract][Full Text] [Related]
10. A survey of DICER1 hotspot mutations in ovarian and testicular sex cord-stromal tumors. Conlon N; Schultheis AM; Piscuoglio S; Silva A; Guerra E; Tornos C; Reuter VE; Soslow RA; Young RH; Oliva E; Weigelt B Mod Pathol; 2015 Dec; 28(12):1603-12. PubMed ID: 26428316 [TBL] [Abstract][Full Text] [Related]
11. Testicular Sertoli cell tumour and potentially testicular Leydig cell tumour are features of Golmard L; Vasta LM; Duflos V; Corsini C; Dubois d'Enghien C; McMaster ML; Harney LA; Carr AG; Ling A; Dijoud F; Gauthier A; Miettinen M; Cost NG; Gauthier-Villars M; Orbach D; Irtan S; Haouy S; Schultz KA; Stoppa-Lyonnet D; Coupier I; Stewart DR; Sirvent N J Med Genet; 2022 Apr; 59(4):346-350. PubMed ID: 33782093 [No Abstract] [Full Text] [Related]
12. Familial multinodular goiter and Sertoli-Leydig cell tumors associated with a large intragenic in-frame Apellaniz-Ruiz M; de Kock L; Sabbaghian N; Guaraldi F; Ghizzoni L; Beccuti G; Foulkes WD Eur J Endocrinol; 2018 Feb; 178(2):K11-K19. PubMed ID: 29187512 [TBL] [Abstract][Full Text] [Related]
13. DICER1-related Sertoli-Leydig cell tumor and gynandroblastoma: Clinical and genetic findings from the International Ovarian and Testicular Stromal Tumor Registry. Schultz KAP; Harris AK; Finch M; Dehner LP; Brown JB; Gershenson DM; Young RH; Field A; Yu W; Turner J; Cost NG; Schneider DT; Stewart DR; Frazier AL; Messinger Y; Hill DA Gynecol Oncol; 2017 Dec; 147(3):521-527. PubMed ID: 29037807 [TBL] [Abstract][Full Text] [Related]
14. Recurrent DICER1 hotspot mutations in endometrial tumours and their impact on microRNA biogenesis. Chen J; Wang Y; McMonechy MK; Anglesio MS; Yang W; Senz J; Maines-Bandiera S; Rosner J; Trigo-Gonzalez G; Grace Cheng SW; Kim J; Matzuk MM; Morin GB; Huntsman DG J Pathol; 2015 Oct; 237(2):215-25. PubMed ID: 26033159 [TBL] [Abstract][Full Text] [Related]
15. DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study. Goulvent T; Ray-Coquard I; Borel S; Haddad V; Devouassoux-Shisheboran M; Vacher-Lavenu MC; Pujade-Laurraine E; Savina A; Maillet D; Gillet G; Treilleux I; Rimokh R Histopathology; 2016 Jan; 68(2):279-85. PubMed ID: 26033501 [TBL] [Abstract][Full Text] [Related]
16. Germline and Somatic DICER1 Mutations in a Well-Differentiated Fetal Adenocarcinoma of the Lung. de Kock L; Bah I; Wu Y; Xie M; Priest JR; Foulkes WD J Thorac Oncol; 2016 Mar; 11(3):e31-3. PubMed ID: 26886166 [TBL] [Abstract][Full Text] [Related]